Andrew Aromando, Chief Business Officer at ONCOLYTICS BIOTECH INC (ONCY), bought 29,600 shares at $0.86 ($25K) on 2026-02-11, disclosed to the SEC on 2026-02-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.